Peter Johnson

• Science & Technology

Brexit: As Article 50 is triggered, what’s next for UK science and patients?

As the UK Government has triggered Article 50, our chief clinician looks at what the Brexit negotiations could mean for cancer. As the UK Government has triggered Article 50, our chief clinician looks at what the Brexit negotiations could mean for cancer.

4 April 2017

• Health & Medicine

New data on cancer treatment to help improve care

Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England. Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England.

31 August 2016

• Health & Medicine

Cancer Drugs Fund decision – ‘How can we deliver personalised treatment with an impersonal funding system?’

Our chief clinician, Professor Peter Johnson, gives his take on the recent announcement of changes to NHS England's Cancer Drugs Fund. Our chief clinician, Professor Peter Johnson, gives his take on the recent announcement of changes to NHS England's Cancer Drugs Fund.

14 January 2015

“We're really struggling to match the demand for cancer treatment”

We caught up with our chief clinician, Professor Peter Johnson, about the findings of a new report looking at the state of NHS cancer services. We caught up with our chief clinician, Professor Peter Johnson, about the findings of a new report looking at the state of NHS cancer services.

8 September 2014